Treace Medical Concepts, Inc.TMCINASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-14.88%
↓ 316% below average
Average (22q)
6.88%
Historical baseline
Range
High:53.87%
Low:-31.47%
Volatility
1240.1%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -14.88% |
| Q2 2025 | -1.15% |
| Q1 2025 | 6.76% |
| Q4 2024 | 4.98% |
| Q3 2024 | -3.76% |
| Q2 2024 | -1.94% |
| Q1 2024 | 26.66% |
| Q4 2023 | -4.55% |
| Q3 2023 | 23.37% |
| Q2 2023 | 3.34% |
| Q1 2023 | -8.99% |
| Q4 2022 | -1.32% |
| Q3 2022 | 27.31% |
| Q2 2022 | -2.23% |
| Q1 2022 | -9.62% |
| Q4 2021 | 33.11% |
| Q3 2021 | 4.75% |
| Q2 2021 | 29.66% |
| Q1 2021 | -2.81% |
| Q4 2020 | 27.20% |
| Q3 2020 | 53.87% |
| Q2 2020 | -31.47% |
| Q1 2020 | 0.00% |